Epimutation and cancer: a new carcinogenic mechanism of Lynch syndrome (Review).

作者: KOUJI BANNO , IORI KISU , MEGUMI YANOKURA , KOSUKE TSUJI , KENTA MASUDA

DOI: 10.3892/IJO.2012.1528

关键词:

摘要: Epimutation is defined as abnormal transcriptional repression of active genes and/or activation usually repressed caused by errors in epigenetic gene repression. arises somatic cells and the germline, constitutional epimutation may also occur. first step tumorigenesis can be a direct cause carcinogenesis. Cancers associated with include Lynch syndrome (hereditary non-polyposis colorectal cancer, HNPCC), chronic lymphocytic leukemia, breast cancer ovarian cancer. has been shown for many tumor suppressor genes, including RB, VHL, hMLH1, APC BRCA1, sporadic cancers. Methylation recently DNA from normal tissues peripheral blood cases studies show constitutive mismatch repair (MMR) (BRCA1, hMLH1 hMSH2) involved development familial cancers found. These results have led to focus on novel oncogenic mechanism.

参考文章(47)
J Toguchida, T Sakai, N Ohtani, D W Yandell, T P Dryja, J M Rapaport, Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. American Journal of Human Genetics. ,vol. 48, pp. 880- 888 ,(1991)
Nicole Benoit, David Sidransky, Michael Kim, Ashok N. Reddy, Joseph A. Califano, Rodney Taylor, John Clinger, Wei W. Jiang, Death-associated protein kinase promoter hypermethylation in normal human lymphocytes. Cancer Research. ,vol. 63, pp. 7694- 7698 ,(2003)
Christopher J. Hussussian, Jeffery P. Struewing, Alisa M. Goldstein, Paul A. T. Higgins, Delphine S. Ally, Michelle D. Sheahan, Wallace H. Clark, Margaret A. Tucker, Nicholas C. Dracopoli, Germline p16 mutations in familial melanoma. Nature Genetics. ,vol. 8, pp. 15- 21 ,(1994) , 10.1038/NG0994-15
Hiromu Naruse, Noriko Ikawa, Kiyoshi Yamaguchi, Yusuke Nakamura, Masami Arai, Chikashi Ishioka, Kokichi Sugano, Kazuo Tamura, Naohiro Tomita, Nagahide Matsubara, Teruhiko Yoshida, Yoshihiro Moriya, Yoichi Furukawa, Determination of splice-site mutations in Lynch syndrome (hereditary non-polyposis colorectal cancer) patients using functional splicing assay. Familial Cancer. ,vol. 8, pp. 509- 517 ,(2009) , 10.1007/S10689-009-9280-6
Marjolijn J L Ligtenberg, Roland P Kuiper, Tsun Leung Chan, Monique Goossens, Konnie M Hebeda, Marsha Voorendt, Tracy Y H Lee, Danielle Bodmer, Eveline Hoenselaar, Sandra J B Hendriks-Cornelissen, Wai Yin Tsui, Chi Kwan Kong, Han G Brunner, Ad Geurts van Kessel, Siu Tsan Yuen, J Han J M van Krieken, Suet Yi Leung, Nicoline Hoogerbrugge, Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 Nature Genetics. ,vol. 41, pp. 112- 117 ,(2009) , 10.1038/NG.283
Megan P. Hitchins, Justin J.L. Wong, Graeme Suthers, Catherine M. Suter, David I.K. Martin, Nicholas J. Hawkins, Robyn L. Ward, Inheritance of a cancer-associated MLH1 germ-line epimutation. The New England Journal of Medicine. ,vol. 356, pp. 697- 705 ,(2007) , 10.1056/NEJMOA064522
KW Kinzler, I Nishisho, Y Nakamura, Y Miyoshi, Y Miki, H Ando, A Horii, K Koyama, J Utsunomiya, S Baba, P Hedge, A Markham, AJ Krush, G Petersen, SR Hamilton, MC Nilbert, DB Levy, TM Bryan, AC Preisinger, KJ Smith, LK Su, B Vogelstein, Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients Science. ,vol. 253, pp. 665- 669 ,(1991) , 10.1126/SCIENCE.1651563
Keiji Hirata, Shuichi Kanemitsu, Yoshifumi Nakayama, Naoki Nagata, Hideaki Itoh, Hideo Ohnishi, Hideki Ishikawa, Yoichi Furukawa, , A novel germline mutation of MSH2 in a hereditary nonpolyposis colorectal cancer patient with liposarcoma. The American Journal of Gastroenterology. ,vol. 101, pp. 193- 196 ,(2006) , 10.1111/J.1572-0241.2005.00308.X
Aurélie Catteau, Joanna R. Morris, BRCA1 methylation: a significant role in tumour development? Seminars in Cancer Biology. ,vol. 12, pp. 359- 371 ,(2002) , 10.1016/S1044-579X(02)00056-1